Invivyd (IVVD) Profit After Tax (2021 - 2025)
Invivyd (IVVD) reported Profit After Tax of -$11.1 million for Q4 2025, up 39.92% on a YoY basis from -$7.9 million in Q4 2024, and down 5.84% quarter-over-quarter from -$10.5 million in Q3 2025.
Invivyd (IVVD) Profit After Tax (2021 - 2025) Analysis & Trends
Invivyd has reported Profit After Tax for 5 years, with the latest figure at -$11.1 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax rose 39.92% year-over-year to -$11.1 million; the trailing twelve-month figure through Dec 2025 stood at -$52.5 million (up 69.1% YoY), and the FY2025 full-year result was -$52.5 million, up 69.1% from the prior year.
- Profit After Tax for Q4 2025 stood at -$11.1 million, down from -$10.5 million in the prior quarter.
- The five-year high for Profit After Tax was -$10.5 million in Q3 2025, with the low at -$100.7 million in Q1 2022.
- Historically, Profit After Tax has averaged -$44.5 million across 5 years, with a median of -$44.6 million in 2021.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 160.12% — and 2025, when it surged 82.76%.
- Invivyd's Profit After Tax stood at -$83.0 million in 2021, then jumped by 46.32% to -$44.6 million in 2022, then tumbled by 65.24% to -$73.7 million in 2023, then surged by 74.96% to -$18.4 million in 2024, then jumped by 39.92% to -$11.1 million in 2025.
- The last three Profit After Tax figures came in at -$11.1 million (Q4 2025), -$10.5 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | -11.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.08 Mn |
| Sep 30, 2025 | -10.47 Mn |
| Jun 30, 2025 | -14.66 Mn |
| Mar 31, 2025 | -16.29 Mn |
| Dec 31, 2024 | -18.44 Mn |
| Sep 30, 2024 | -60.74 Mn |
| Jun 30, 2024 | -47.25 Mn |
| Mar 31, 2024 | -43.50 Mn |
| Dec 31, 2023 | -73.65 Mn |
| Sep 30, 2023 | -39.44 Mn |
| Jun 30, 2023 | -50.23 Mn |
| Mar 31, 2023 | -35.32 Mn |
| Dec 31, 2022 | -44.57 Mn |
| Sep 30, 2022 | -45.09 Mn |
| Jun 30, 2022 | -50.99 Mn |
| Mar 31, 2022 | -100.67 Mn |
| Dec 31, 2021 | -83.04 Mn |
| Sep 30, 2021 | -60.38 Mn |
| Jun 30, 2021 | -44.67 Mn |
| Mar 31, 2021 | -38.70 Mn |